Xyall, Indica Labs Partner to Improve Precision Oncology Workflows
Xyall and Indica Labs’ strategic partnership is designed to bridge the gap between histology and molecular pathology.
Read MorePosted by Melanie Hamilton-Basich | Apr 28, 2023 | Molecular Diagnostics |
Xyall and Indica Labs’ strategic partnership is designed to bridge the gap between histology and molecular pathology.
Read MorePosted by Melanie Hamilton-Basich | Oct 8, 2020 | Digital Pathology |
The goal is to develop an automated, high-precision table-top tumor tissue dissection solution for hospital-based molecular pathology laboratories.
Read MorePosted by | Feb 29, 2020 | Anatomic Pathology, Molecular Diagnostics, Tissue Processing |
The investment is to fast-track the development, manufacture, and commercialization of a fully automated, high-precision tumor tissue dissection solution for global molecular pathology laboratories.
Read MorePosted by Chris Wolski | Aug 5, 2024 | Molecular Diagnostic Analyzers |
Indica Labs’ Lung Macrodissect AI, an AI-powered tool designed to enhance slide macrodissection and molecular pathology workflows.
Read More